A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
Clinical trial NCT00755287 · COMPLETED
Trial details
- NCT number
- NCT00755287
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-12-01
- Enrollment
- 1072
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.